Mon, July 26, 2021

Colin Bristow Initiated (ABOS) at Strong Buy and Held Target at $27 on, Jul 26th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-27-on-jul-26th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Colin Bristow of UBS, Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $27 on, Jul 26th, 2021.

Colin, nor any peers, have made any analyst calls on ABOS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30